Vuong Trieu, CHAIRMAN AND CEO, 10% Owner at Oncotelic Therapeutics, Inc. (OTLC), bought 20,000 shares at $0.07 ($1K) on 2022-09-26, disclosed to the SEC on 2022-09-28.
Open-market purchase of $1k OTLC by CHAIRMAN AND CEO, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| OTLC | BUY | 2026-06-17 | $15K | — | Filing → |
| OTLC | BUY | 2025-07-10 | $2K | — | Filing → |
| OTLC | BUY | 2025-01-31 | $10K | — | Filing → |